Allergy to laxative compound (Plantago ovata seed) among health care professionals.
BACKGROUND
The seeds of Plantago ovata (psyllium, ispaghula) used in the manufacture of bulk laxatives are known to be the cause of occupational allergy (rhinitis, asthma) in health care and pharmaceutical workers.


OBJECTIVE
We studied the prevalence of P ovata seed allergy among health care workers in geriatric care homes and compared it with a group of health care professionals not exposed to P ovata seed. Cross reactivity with Plantago lanceolata pollen was also studied.


METHODS
Two groups of health professionals were recruited: 58 health care workers from geriatric care homes who were exposed daily to laxatives containing P ovata and 63 nonexposed health care professionals. The prevalence of allergy and sensitization to P ovata seed was determined based on clinical history, skin prick test, and analysis of specific immunoglobulin (Ig) E. IgE immunoblotting was performed to calculate the molecular weights of the P ovata seed allergens. Cross reactivity to P lanceolata pollen was studied by enzyme allergosorbent test (EAST) and immunoblot inhibition techniques.


RESULTS
The prevalence of sensitization and clinical allergy to P ovata seed in the exposed group was 13.8% and 8.6%, respectively. No sensitization was observed in the nonexposed group. IgE-binding proteins of 17, 20, 25, 32-34, 54, 73-77, and > 97 kDa were identified. EAST inhibition and immunoblot inhibition demonstrated the existence of cross reactivity between P ovata seed and P lanceolata pollen extracts.


CONCLUSIONS
The rate of sensitization to P ovata seed is high among health care workers in geriatric care homes (13.8%). A mild cross reactivity between P ovata seed and P lanceolata pollen was observed.
Department of Allergy and Immunology, Santiago Apostol Hospital, Vitoria-Gasteiz, Spain. nagore.bernedobelar@osakidetza.net
N
N
Bernedo
M
M
García
G
G
Gastaminza
E
E
Fernández
B
B
Bartolomé
J
J
Algorta
D
D
Muñoz
D000328:Adult; D000485:Allergens / Q000276:immunology; D003429:Cross Reactions; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology* / Q000276:immunology; D007073:Immunoglobulin E / Q000097:blood*; D054368:Laxatives; D008297:Male; D008875:Middle Aged; D009726:Nurses; D009784:Occupational Diseases / Q000453:epidemiology* / Q000276:immunology; D010943:Plantago / Q000276:immunology; D011058:Pollen / Q000276:immunology; D015995:Prevalence; D011620:Psyllium / Q000276:immunology*; D012882:Skin Tests; D013030:Spain / Q000453:epidemiology
D000485:Allergens; D054368:Laxatives; D007073:Immunoglobulin E; D011620:Psyllium